Laboratory revenue cycle management encompasses every operational process connecting clinical laboratory services to collected Medicare reimbursement – and in August 2026, it has become the most actionable lever available to laboratory executives preparing for a confirmed payment shift. The Consolidated Appropriations Act, 2026, signed February 3, 2026, delayed all PAMA-related Clinical Laboratory Fee Schedule (CLFS) rate reductions through December 31, 2026 – the seventh Congressional intervention since PAMA was enacted [1]. But the reprieve is temporary.

Home health billing companies and revenue cycle leaders in home health settings are navigating a rapidly tightening enfo...
read more
The CMS Transforming Episode Accountability Model (TEAM) is in play, and its impact on orthopedic billing services will ...
read more
On May 13, 2026, the Centers for Medicare and Medicaid Services imposed an unprecedented nationwide six-month moratorium...
read more
Most healthcare organizations don't decide to outsource medical billing because of a single crisis. The decision builds ...
read more
In 2025, U.S. hospitals spent $18 billion overturning claims denials. Not losing those claims. Not writing them off. Ov...
read more
Workforce pressures on billing for home health services are impacted every time The Centers for Medicare & Medicaid Serv...
read more
The home health revenue cycle has officially entered its “Prove It” era. For years, many home health agencies approache...
read more
The healthcare revenue cycle has recently seen a flurry of coding solutions from some of the most recognized names in AI...
read more
Fraud detection has taken center stage with this administration, and the latest effort is the Comprehensive Regulations ...
read more